Abian Pharmed

Abian Pharmed entered Iran’s pharmaceutical industry in 2017, focusing on extensive research and development with a science-driven and expertise-based approach. The company's top priority has always been to collaborate with leading domestic and international experts and researchers to produce specialized medicines of the highest quality, adhering to international standards.
Abian Pharmed's product portfolio includes treatments for neurology and central nervous system (CNS) disorders—such as Parkinson’s, epilepsy, and neuropsychiatric conditions—as well as cardiovascular, kidney, and urinary tract diseases, digestive disorders, oncology, general medicines, and pediatric supplement syrups.
Abian Pharmed's primary goal is to develop and supply essential specialized medicines to meet patient needs and ensure their availability in the market.